Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal

Summary

Stopping prescription opioid pain medications can be difficult due to withdrawal symptoms. This study will test if LUCEMYRA helps reduce withdrawal symptoms and helps more people reduce their opioid dose compared to placebo.

Timeline

Start

2019-08-02

Primary completion

2019-11-27

Completion

2019-11-27

Outcome

Outcome not reported

Stopped (Enrollment): “COVID pandemic and enrollment issues necessitating an adjustment to the study design.”

Drugs

Indications